About: Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 September 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) bài báo khoa học (vi) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована у вересні 2008 (uk) scientific article published on 17 September 2008 (en) مقالة علمية نشرت في 17 سبتمبر 2008 (ar)
publication date	wds:Q37281713-B90A1A99-0051-450A-B263-73648D916858
publication date	2008-09-17 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37281713-A9430A92-1F3C-4D02-A7F7-7383CEFB1EAE
language of work or name	English
author name string	wds:Q37281713-359CC539-C674-4C62-8A2A-B80A04A534CA wds:Q37281713-3640ABDB-9E0E-4878-8629-C1E6DBA28474 wds:Q37281713-4E410C82-EFAC-4E3B-B7C8-57A607B66DD9 wds:Q37281713-B7598483-FBC6-4B35-B32A-CB131B398D15 wds:Q37281713-D0FAF1F0-ADDB-4F1F-9038-4407E388BE3E wds:Q37281713-ED3A27AA-D131-4ED8-9266-CD87D641A0E9 wds:Q37281713-F2776007-AEBE-4261-8C6B-E45279ACAF0F wds:Q37281713-FDC55472-A3FF-45ED-A798-56215A0968D3
author name string	Prokar Dasgupta Antonella Giannantoni Brigitte Schurch Clare J Fowler Sohier Elneil Apostolos Apostolidis Heinrich Schulte-Baukloh European Consensus Panel
rdfs:label	Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (en) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (nl) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (ast)
skos:prefLabel	Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (en) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (nl) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (ast)
name	Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (en) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (nl) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. (ast)
author	wds:Q37281713-3C23DAA8-8B7C-43CF-84D4-325971832AE0 wds:Q37281713-B4AC514D-775F-4AF9-AB92-FAB75DDC0AFE wds:Q37281713-E56E6946-034F-45CF-8318-42881AAE0F02
author	Gilles Karsenty Pierre Denys Jean-Jacques Wyndaele
title	wds:Q37281713-82F78E7E-FEDB-4CF9-AA59-DDA789039AAB
title	Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report (en)
page(s)	wds:Q37281713-F8671385-92E9-44DC-96F6-A3A28C3E1335
page(s)	100-119
instance of	wds:Q37281713-0d20329c-c942-4a20-ad61-d89167410b26 wds:Q37281713-78CEAE18-15CD-4561-BCC9-A537EA6C2AA1
instance of	review article scholarly article
PubMed ID	wds:Q37281713-A21C9154-4C1C-446D-9998-62C6E3B3BB63
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18823697
PubMed ID	18823697
published in	wds:Q37281713-1AEB97EB-CD17-43B8-BBFC-8E1C66FD4BE5
published in	European Urology
issue	wds:Q37281713-971D8EAB-2A5E-4752-AAEF-3F9D245C9C75
volume	wds:Q37281713-1F54E721-FD8D-475E-BC57-4244147416B0
issue	1
volume	55
DOI	wds:Q37281713-D6395175-7F96-451A-ABED-333D2F6053FC
DOI	http://dx.doi.org/10.1016/J.EURURO.2008.09.009
DOI	10.1016/J.EURURO.2008.09.009
ResearchGate publication ID	wds:Q37281713-62A4AC87-1A66-428B-8029-3CA25E266189
ResearchGate publication ID	23286933
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37281713
is cites work of	Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature Neuromodulation for intractable OAB. Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain Targets for botulinum toxin in the lower urinary tract Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity. Repeated Injections of Botulinum Toxin-A for Idiopathic Detrusor Overactivity Voiding dysfunction after pelvic colorectal surgery Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder. Onabotulinum toxin a (botox®) in the treatment of neurogenic bladder overactivity Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2X2, and P2X3 receptors in children and adolescents who have neurogenic detrusor overactivity: a single-blind study Botulinum toxin-A for the treatment of overactive bladder: UK contributions Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity. Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany. Challenges and current evidence on the management of bladder pain syndrome Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: long-term urodynamic findings The effects of long-term medical treatment combined with clean intermittent catheterization in children with neurogenic detrusor overactivity. Overactive bladder in children Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis [Botulinum toxin for neurogenic bladder dysfunction].

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software